Accessibility Menu
Genomma Lab InternacionalB. De C.v. Stock Quote

Genomma Lab InternacionalB. De C.v. (OTC: GNMLF)

$1.00
(-3.8%)
-0.04
Price as of February 2, 2026, 9:30 a.m. ET

KEY DATA POINTS

Current Price
$1.00
Daily Change
(-3.8%) $0.04
Day's Range
$1.00 - $1.00
Previous Close
$1.00
Open
$1.00
Beta
0.08
Volume
100
Average Volume
540
Market Cap
$1,000M
Market Cap / Employee
$1.00M
52wk Range
$0.93 - $1.43
Revenue
N/A
Gross Margin
0.63%
Dividend Yield
3.26%
EPS
$0.09
CAPs Rating
N/A
Industry
Pharmaceuticals

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Genomma Lab InternacionalB. De C.v. Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
GNMLF-18.35%-20.43%-4.47%-49%
S&P+15.58%+78.13%+12.24%+409%

Genomma Lab InternacionalB. De C.v. Company Info

Genomma Lab Internacional SAB de CV engages in the development, manufacturing and marketing of pharmaceutical, beauty and personal care products. The company was founded by Rodrigo Alonso Herrera Aspra on October 30, 1996 and is headquartered in Mexico City, Mexico.

News & Analysis

No results found

No news articles found for Genomma Lab InternacionalB. De C.v..

Financial Health

General

Q3 2025YOY Change
Revenue$238.42M-11.4%
Gross Profit$152.25M-11.9%
Gross Margin63.86%-0.4%
Market Cap$1.17B1.5%
Market Cap / Employee$685.01K-3.0%
Employees1.7K4.7%
Net Income$23.30M-33.2%
EBITDA$53.73M-15.3%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q3 2025YOY Change
Net Cash$123.55M46.1%
Accounts Receivable$274.36M12.9%
Inventory1488.7%

Liabilities

Q3 2025YOY Change
Long Term Debt$271.45M-0.1%
Short Term Debt$132.92M96.0%

Ratios

Q3 2025YOY Change
Return On Assets7.20%0.2%
Return On Invested Capital10.63%1.8%

Cash Flow

Q3 2025YOY Change
Free Cash Flow$7.77M-88.1%
Operating Free Cash Flow$15.25M-77.2%

Valuation

MetricQ4 2024Q1 2025Q2 2025Q3 2025YoY Change
Price to Earnings9.839.9210.3711.46-8.61%
Price to Book2.112.512.051.924.25%
Price to Sales1.161.221.111.110.16%
Price to Tangible Book Value4.745.444.624.105.88%
Price to Free Cash Flow TTM19.2819.9714.56451.161677.29%
Enterprise Value to EBITDA24.9128.0123.3924.3014.59%
Free Cash Flow Yield5.2%5.0%6.9%0.2%-94.37%
Return on Equity21.6%21.1%17.2%15.3%4.04%
Total Debt$312.01M$344.68M$385.71M$404.37M19.07%

No results found

No podcast episodes available.

No results found

No transcripts available.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.